Ferguson Wellman Capital Management Inc. Sells 13,115 Shares of Procter & Gamble Company (The) $PG

Ferguson Wellman Capital Management Inc. lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 889,377 shares of the company’s stock after selling 13,115 shares during the period. Procter & Gamble comprises approximately 1.6% of Ferguson Wellman Capital Management Inc.’s investment portfolio, making the stock its 16th biggest position. Ferguson Wellman Capital Management Inc.’s holdings in Procter & Gamble were worth $130,418,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of PG. E Fund Management Hong Kong Co. Ltd. boosted its holdings in Procter & Gamble by 1,000.0% during the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock valued at $25,000 after acquiring an additional 150 shares during the period. Park Square Financial Group LLC increased its stake in Procter & Gamble by 65.1% in the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after purchasing an additional 71 shares during the period. Evolution Wealth Management Inc. increased its stake in Procter & Gamble by 1,315.4% in the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock worth $26,000 after purchasing an additional 171 shares during the period. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of Procter & Gamble during the second quarter worth $26,000. Finally, Litman Gregory Wealth Management LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter valued at $26,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Procter & Gamble

In related news, CAO Matthew W. Janzaruk sold 359 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer owned 1,271 shares of the company’s stock, valued at $184,600.04. The trade was a 22.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Susan Street Whaley sold 2,238 shares of the company’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $321,802.02. Following the sale, the insider owned 26,989 shares of the company’s stock, valued at approximately $3,880,748.31. This represents a 7.66% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 6,627 shares of company stock valued at $953,417 over the last ninety days. 0.20% of the stock is owned by company insiders.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Several recent articles identify PG as a leading dividend stock for 2027 and beyond, emphasizing its dependable income, long record of dividend growth and resilience across economic cycles. This supports demand from income-oriented and defensive investors. The Best Dividend Stock for 2027 and Beyond: Procter & Gamble
• Positive Sentiment: PG is being presented as an attractive alternative to simply owning the Consumer Staples Select Sector SPDR Fund (XLP), reflecting investor interest in selecting high-quality individual dividend payers with established household brands. These 3 Dividend Stocks Make a Strong Case for Skipping XLP
• Neutral Sentiment: The bullish investment case also depends on productivity improvements, new product innovation and robust cash returns. Those factors could help offset modest underlying growth, although PG’s valuation remains relatively rich. Is P&G Stock Worth Buying as Growth Slows and Valuation Stays Rich?
• Negative Sentiment: Analysts highlight an estimated 8% fiscal 2027 core EPS headwind from higher input costs, financing expenses, lower non-operating income and unfavorable currency movements. These pressures could limit earnings growth and weigh on the stock’s premium valuation. P&G Fiscal 2027 Outlook Brings an 8% Core EPS Headwind Into Focus
• Negative Sentiment: Erste Group Bank issued a bearish forecast for PG’s fiscal 2027 earnings, reinforcing concerns that the company’s near-term fundamentals may not justify its valuation. Erste Group Bank Has Bearish Forecast for PG FY2027 Earnings

Wall Street Analyst Weigh In

A number of research analysts have recently commented on PG shares. Barclays upped their price target on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Argus lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. HSBC reissued a “hold” rating and issued a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research report on Wednesday, June 24th. Finally, Citigroup decreased their price target on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Thirteen equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $161.19.

Procter & Gamble Stock Performance

PG stock opened at $145.51 on Tuesday. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25. The business has a 50-day moving average price of $147.06 and a 200 day moving average price of $148.12. The company has a market capitalization of $338.23 billion, a P/E ratio of 21.98, a PEG ratio of 4.43 and a beta of 0.39. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47.

Procter & Gamble (NYSE:PG) last issued its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.02. The company had revenue of $21.20 billion for the quarter, compared to analysts’ expectations of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The firm’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, equities research analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 17th. Investors of record on Friday, July 24th were issued a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend was Friday, July 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.71%.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.